A longitudinal validation of the EQ-5D-5L and EQ-VAS stand-alone component utilising the Oxford Hip Score in the Australian hip arthroplasty population
Abstract Purpose To evaluate the measurement properties of the Oxford Hip Score (OHS), EQ-5D-5L utility index and EQ-5D-5L visual analogue scale (EQ-VAS) in patients undergoing elective total hip arthroplasty in Australia. Methods In this prospective multi-centre study, the OHS and EQ-5D-5L were col...
| Published in: | Journal of Patient-Reported Outcomes |
|---|---|
| Main Authors: | D-Yin Lin, Tim Soon Cheok, Anthony J. Samson, Billingsley Kaambwa, Brigid Brown, Christopher Wilson, Hidde M. Kroon, Ruurd L. Jaarsma |
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2022-06-01
|
| Online Access: | https://doi.org/10.1186/s41687-022-00482-7 |
Similar Items
Evaluation of the EQ-5D-5L, EQ-VAS stand-alone component and Oxford knee score in the Australian knee arthroplasty population utilising minimally important difference, concurrent validity, predictive validity and responsiveness
by: D-Yin Lin, et al.
Published: (2023-05-01)
by: D-Yin Lin, et al.
Published: (2023-05-01)
Why EQ-5D and the Oxford Hip and Knee scores do not measure the same things
by: Tim Benson
Published: (2025-06-01)
by: Tim Benson
Published: (2025-06-01)
Short-term difference only in reported outcomes (PROMs) after anterior or posterior approach to total hip arthroplasty: a 4-year prospective multi-centre observational study
by: D-Yin Lin, et al.
Published: (2023-02-01)
by: D-Yin Lin, et al.
Published: (2023-02-01)
A scoping review of the use of minimally important difference of EQ-5D utility index and EQ-VAS scores in health technology assessment
by: Caroline Shaw, et al.
Published: (2024-08-01)
by: Caroline Shaw, et al.
Published: (2024-08-01)
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
by: Cella David, et al.
Published: (2010-01-01)
by: Cella David, et al.
Published: (2010-01-01)
Correction to: Assessing responsiveness of the EQ-5D-3L, the Oxford Hip Score, and the Oxford Knee Score in the NHS patient-reported outcome measures
by: Sujin Kang
Published: (2021-02-01)
by: Sujin Kang
Published: (2021-02-01)
EQ-5D-3L and EQ-5D-5L population norms for Thailand
by: Krittaphas Kangwanrattanakul, et al.
Published: (2024-04-01)
by: Krittaphas Kangwanrattanakul, et al.
Published: (2024-04-01)
Population norms for the EQ-5D-3L and EQ-5D-5L in Romania
by: Elena Olariu, et al.
Published: (2023-07-01)
by: Elena Olariu, et al.
Published: (2023-07-01)
Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden
by: Fitsum Sebsibe Teni, et al.
Published: (2023-04-01)
by: Fitsum Sebsibe Teni, et al.
Published: (2023-04-01)
Reporting and valuing one’s own health: a think aloud study using EQ-5D-5L, EQ VAS and a time trade-off question among patients with a chronic condition
by: Olivia Ernstsson, et al.
Published: (2020-12-01)
by: Olivia Ernstsson, et al.
Published: (2020-12-01)
Mapping analysis to predict EQ-5D-5 L utility values based on the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) questionnaires in the Spanish population suffering from lower limb osteoarthritis
by: Jesús Martín-Fernández, et al.
Published: (2020-06-01)
by: Jesús Martín-Fernández, et al.
Published: (2020-06-01)
Comparison of the EQ-5D-3L and EQ-5D-5L instruments in patients undergoing unicompartmental knee arthroplasty
by: Zhipeng Tai, et al.
Published: (2025-01-01)
by: Zhipeng Tai, et al.
Published: (2025-01-01)
Comparison of the EQ-5D-Y-5L, EQ-5D-Y-3L and PedsQL in children and adolescents
by: Janine Verstraete, et al.
Published: (2022-06-01)
by: Janine Verstraete, et al.
Published: (2022-06-01)
Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys
by: Marc Martí-Pastor, et al.
Published: (2018-08-01)
by: Marc Martí-Pastor, et al.
Published: (2018-08-01)
EQ-5D self-reported health in Barbados and Jamaica with EQ-5D-5L population norms for the English-speaking Caribbean
by: Henry Bailey, et al.
Published: (2021-03-01)
by: Henry Bailey, et al.
Published: (2021-03-01)
The Exocyst Subunits EqSec5 and EqSec6 Promote Powdery Mildew Fungus Growth and Pathogenicity
by: Jinyao Yin, et al.
Published: (2025-01-01)
by: Jinyao Yin, et al.
Published: (2025-01-01)
VALIDATION OF THE EQ-5D-5L VERSION IN RUSSIA
by: A. I Akulova, et al.
Published: (2018-07-01)
by: A. I Akulova, et al.
Published: (2018-07-01)
A head-to-head comparison of the adult EQ-5D-5L and youth EQ-5D-Y-5L in adolescents with idiopathic scoliosis
by: Joshua M. Bonsel, et al.
Published: (2025-01-01)
by: Joshua M. Bonsel, et al.
Published: (2025-01-01)
The performance of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents with cerebral palsy (CP)
by: Janine Verstraete, et al.
Published: (2022-12-01)
by: Janine Verstraete, et al.
Published: (2022-12-01)
Mapping of disease-specific Oxford Knee Score onto EQ-5D-5L utility index in knee osteoarthritis
by: Hadeer Fawaz, et al.
Published: (2023-02-01)
by: Hadeer Fawaz, et al.
Published: (2023-02-01)
Exploring differences and similarities of EQ-5D-3L, EQ-5D-5L and WHOQOL-OLD in recipients of aged care services in Germany.
by: Ole Marten, et al.
Published: (2023-01-01)
by: Ole Marten, et al.
Published: (2023-01-01)
33 Improved EQ-5D-5L outcomes after non-surgically and surgically treated hip abductor pathology: a retrospective study
by: Jeppe Lange, et al.
Published: (2024-02-01)
by: Jeppe Lange, et al.
Published: (2024-02-01)
Scale and rate heterogeneity in the EQ-5D-5L valuation
by: Maksat Jumamyradov, et al.
Published: (2024-07-01)
by: Maksat Jumamyradov, et al.
Published: (2024-07-01)
The EQ-5D-5L valuation study for Trinidad and Tobago
by: Henry Bailey, et al.
Published: (2024-07-01)
by: Henry Bailey, et al.
Published: (2024-07-01)
Crosswalk EQ-5D-5L Value Set for Slovenia
by: Prevolnik Rupel Valentina, et al.
Published: (2020-06-01)
by: Prevolnik Rupel Valentina, et al.
Published: (2020-06-01)
An analysis of Euroqol EQ-5D and Manchester Oxford Foot Questionnaire scores six months following podiatric surgery
by: Maher Anthony J, et al.
Published: (2012-07-01)
by: Maher Anthony J, et al.
Published: (2012-07-01)
The validity of the Shona version of the EQ-5D, of life measure
by: J. M. Jelsma
Published: (2002-01-01)
by: J. M. Jelsma
Published: (2002-01-01)
Mapping onto Eq-5 D for patients in poor health
by: Brazier John E, et al.
Published: (2010-11-01)
by: Brazier John E, et al.
Published: (2010-11-01)
A Qualitative Examination of the Content Validity of the EQ‐5D‐5L and EQ‐5D‐Y‐3L in Adult and Paediatric Patients With Duchenne Muscular Dystrophy
by: Richard Huan Xu, et al.
Published: (2025-10-01)
by: Richard Huan Xu, et al.
Published: (2025-10-01)
Health Related Quality of Life norm data of the Italian general population: results using the EQ-5D-3L and EQ-5D-5L instruments
by: Luciana Scalone, et al.
Published: (2015-09-01)
by: Luciana Scalone, et al.
Published: (2015-09-01)
Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi
by: Lucky G. Ngwira, et al.
Published: (2023-03-01)
by: Lucky G. Ngwira, et al.
Published: (2023-03-01)
Health Related Quality of Life norm data of the Italian general population: results using the EQ-5D-3L and EQ-5D-5L instruments
by: Luciana Scalone, et al.
Published: (2022-05-01)
by: Luciana Scalone, et al.
Published: (2022-05-01)
The EQ-5D and EQ-HWB fit the perceptions of quality of life from a Chinese perspective: a concept mapping study
by: Yifan Ding, et al.
Published: (2025-03-01)
by: Yifan Ding, et al.
Published: (2025-03-01)
Isomorphisms in EQ-Algebras
by: Bakhshi M., et al.
Published: (2020-12-01)
by: Bakhshi M., et al.
Published: (2020-12-01)
EQ-5D-5L norms for the urban Chinese population in China
by: Zhihao Yang, et al.
Published: (2018-11-01)
by: Zhihao Yang, et al.
Published: (2018-11-01)
VAS value set still has its own application value compare with TTO value set of EQ-5D-3L in Chinese population
by: Lin Zhuo, et al.
Published: (2025-06-01)
by: Lin Zhuo, et al.
Published: (2025-06-01)
Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol
by: Knut Stavem, et al.
Published: (2020-06-01)
by: Knut Stavem, et al.
Published: (2020-06-01)
Comparison of the measurement properties and consistency between the EQ-5D-3L and EQ-5D-Y-3L in adolescents aged 15–17 in China
by: Jiefu Wang, et al.
Published: (2024-07-01)
by: Jiefu Wang, et al.
Published: (2024-07-01)
Health-related quality of life in primary care patients: a comparison between EQ-5D-5L utility score and EQ-visual analogue scale
by: Richard Huan Xu, et al.
Published: (2024-01-01)
by: Richard Huan Xu, et al.
Published: (2024-01-01)
How to interpret patient-reported outcomes? - Stratified adjusted minimal important changes for the EQ-5D-3L in hip and knee replacement patients
by: Irene Salvi, et al.
Published: (2024-11-01)
by: Irene Salvi, et al.
Published: (2024-11-01)
Similar Items
-
Evaluation of the EQ-5D-5L, EQ-VAS stand-alone component and Oxford knee score in the Australian knee arthroplasty population utilising minimally important difference, concurrent validity, predictive validity and responsiveness
by: D-Yin Lin, et al.
Published: (2023-05-01) -
Why EQ-5D and the Oxford Hip and Knee scores do not measure the same things
by: Tim Benson
Published: (2025-06-01) -
Short-term difference only in reported outcomes (PROMs) after anterior or posterior approach to total hip arthroplasty: a 4-year prospective multi-centre observational study
by: D-Yin Lin, et al.
Published: (2023-02-01) -
A scoping review of the use of minimally important difference of EQ-5D utility index and EQ-VAS scores in health technology assessment
by: Caroline Shaw, et al.
Published: (2024-08-01) -
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
by: Cella David, et al.
Published: (2010-01-01)
